The worldwide market for drug-eluting, as well as bare, bioresorbable and other stents, is now the subject of the May 2009 report by MedMarket Diligence, Report #C245. Below is an excerpt from MedMarket Diligence’s coverage of the drug-eluting stents market in mid-2008. The previous scarcity of long term data left some uncertainty about DES’ clinical and [...]
[Through the course of researching and analyzing coronary artery disease treatments, technologies and markets for our May 2009 worldwide coronary stents market report, we have compiled data on the ancillary market of drug-eluting balloons, which we synopsize below.] Drug-Eluting Balloons A handful of companies are developing drug-coated balloon catheters as an alternative to balloon angioplasty and [...]
There is certainly the possibility (despite my doubts) that the current economic slowdown in global markets will have major effects on the medical technology industry. One simply cannot deny that there is simply less VC or other cash floating around that might be put to medtech investment. And maybe, as has occurred in the past [...]
Contact:
